VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s stock price hit a new 52-week low on Thursday. The stock traded as low as C$0.07 and last traded at C$0.07, with a volume of 168,430 shares changing hands. The stock had previously closed at C$0.07.
VentriPoint Diagnostics Price Performance
The stock has a market cap of C$13.50 million, a price-to-earnings ratio of -3.50 and a beta of -1.31. The stock has a fifty day simple moving average of C$0.09 and a 200-day simple moving average of C$0.11. The company has a current ratio of 0.12, a quick ratio of 6.67 and a debt-to-equity ratio of -68.25.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients.
Recommended Stories
- Five stocks we like better than VentriPoint Diagnostics
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
